NAD+ 1000MG & RETATRUTIDE : A UK NEWS

The emerging interest in NAD+ supplementation, particularly at a high dosage of one gram, continues to rise within the British medical community. Simultaneously , attention is directed toward Retatrutide, a novel GLP-1 receptor agonist being viewed by many as a potential advancement to Tirzepatid